Why did the doctors prescribe mirtazapine after I stopped Latuda (lurasidone) abruptly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Why Mirtazapine Was Prescribed After Abruptly Stopping Latuda

Your doctors likely prescribed mirtazapine to manage withdrawal symptoms and address underlying conditions (depression, anxiety, insomnia) that emerged or worsened after abruptly discontinuing Latuda, while providing a safer medication profile during this transition period.

Understanding the Clinical Context

The Problem with Abrupt Latuda Discontinuation

Stopping Latuda (lurasidone) suddenly creates several clinical challenges that mirtazapine specifically addresses:

Discontinuation syndrome occurs when antipsychotics like Latuda are stopped abruptly rather than tapered 1. The FDA label for Latuda does not specifically mandate tapering, but clinical practice strongly favors gradual dose reduction to avoid rebound symptoms 2. When you stopped cold turkey, you likely experienced:

  • Rebound psychiatric symptoms - Return or worsening of the original condition Latuda was treating (bipolar depression, schizophrenia, or psychotic symptoms)
  • Withdrawal effects - Dizziness, agitation, anxiety, insomnia, nausea, and sensory disturbances
  • Sleep disruption - A particularly prominent issue given Latuda's sedating properties

Why Mirtazapine Was the Logical Choice

Mirtazapine addresses multiple problems simultaneously, making it an ideal bridge medication in your situation:

Primary Reasons for Mirtazapine Selection

1. Rapid Management of Withdrawal Symptoms

Mirtazapine effectively treats several symptoms that emerge during antipsychotic discontinuation 3:

  • Anxiety and agitation - Common withdrawal symptoms that mirtazapine addresses through its unique noradrenergic and serotonergic mechanism 4, 5
  • Insomnia - Mirtazapine has potent sedating effects, particularly useful when Latuda's discontinuation disrupts sleep 4, 6
  • Nausea - A frequent withdrawal symptom that mirtazapine can alleviate 7

2. Treatment of Underlying Psychiatric Conditions

If Latuda was prescribed for bipolar depression or depression with psychotic features, mirtazapine serves as appropriate continuation therapy:

For depression with anxiety: Mirtazapine demonstrates efficacy comparable to SSRIs and tricyclic antidepressants, with particular advantages for patients experiencing both depression and anxiety 8, 9. Recent evidence shows mirtazapine may be slightly superior to SSRIs specifically for anxiety symptoms in major depressive disorder 8.

For bipolar depression: While not a first-line monotherapy for bipolar disorder, mirtazapine can be used cautiously, particularly when combined with mood stabilizers 5. Your doctors likely weighed the risk of inducing mania (which mirtazapine carries at lower rates than traditional antidepressants) against the immediate need to stabilize your symptoms 7.

3. Favorable Safety Profile During Transition

Mirtazapine offers several safety advantages during this vulnerable period:

  • Cardiovascular safety - Unlike tricyclic antidepressants, mirtazapine has been shown safe in patients with cardiovascular disease, with minimal effects on blood pressure and heart rate 6
  • Low seizure risk - Only 1 seizure reported among 2,796 patients in premarketing trials 7
  • Minimal drug interactions - Unlike many antidepressants, mirtazapine has low potential for cytochrome P450-mediated drug interactions 10, 11

4. Additional Therapeutic Benefits

Mirtazapine provides bonus effects that may have been clinically relevant:

  • Appetite stimulation and weight gain - If you experienced appetite loss or weight loss during your psychiatric illness or Latuda treatment, mirtazapine's tendency to increase appetite becomes therapeutic rather than problematic 5, 6, 7
  • Rapid onset - Some evidence suggests mirtazapine may work faster than SSRIs, with improvements noted within 1 week 12, 9

The Clinical Algorithm Your Doctors Likely Followed

Step 1: Assess Immediate Symptoms

After abrupt Latuda discontinuation, your doctors evaluated:

  • Severity of withdrawal symptoms (anxiety, insomnia, agitation)
  • Return of underlying psychiatric symptoms (depression, psychosis)
  • Physical symptoms (nausea, dizziness, autonomic instability)

Step 2: Choose Appropriate Intervention

Guidelines recommend sedating antidepressants like mirtazapine as appropriate options for managing insomnia and anxiety in psychiatric patients 4, 5, 6. The choice between mirtazapine, trazodone, or other options likely came down to:

  • Mirtazapine was preferred if: You had prominent anxiety, needed appetite stimulation, or required rapid symptom relief
  • Mirtazapine over trazodone: Less anticholinergic activity and potentially better efficacy 4
  • Mirtazapine over SSRIs: Faster onset, better for sleep, and superior for anxiety symptoms in depression 8, 9

Step 3: Dosing Strategy

Typical mirtazapine initiation follows this pattern 7:

  • Starting dose: 7.5-15 mg at bedtime (lower doses are actually MORE sedating due to histamine effects)
  • Therapeutic range: 15-45 mg daily
  • Timing: Evening administration to leverage sedative effects for sleep

Important Caveats and Monitoring

What to Watch For

Common side effects you should expect 7:

  • Drowsiness (especially in first 1-2 weeks)
  • Increased appetite and weight gain
  • Dry mouth
  • Dizziness when standing (orthostatic hypotension)

Serious but rare concerns requiring immediate medical attention 7:

  • Agranulocytosis - Fever, chills, sore throat, or signs of infection (extremely rare but serious)
  • Serotonin syndrome - If combined with other serotonergic drugs
  • Activation of mania - Particularly relevant given your Latuda history suggests possible bipolar disorder

The Tapering Plan

Do not stop mirtazapine abruptly - you've already experienced the problems with cold-turkey discontinuation 7. When the time comes to discontinue mirtazapine, your doctor should taper gradually over 1-2 weeks minimum to avoid withdrawal symptoms including dizziness, sensory disturbances, anxiety, and nausea.

Why Not Just Restart Latuda?

Your doctors chose mirtazapine over restarting Latuda for several possible reasons:

  1. Latuda requires food - Must be taken with at least 350 calories, which complicates adherence 2
  2. Latuda's side effect profile - May have caused problems (akathisia, nausea, restlessness) that contributed to discontinuation
  3. Cost and availability - Latuda is expensive; mirtazapine is generic and affordable
  4. Reassessment opportunity - Stopping Latuda allows evaluation of whether you truly need an antipsychotic versus an antidepressant

Bottom Line

Mirtazapine serves as both a treatment for withdrawal symptoms from abrupt Latuda discontinuation AND continuation therapy for your underlying psychiatric condition. Its unique pharmacological profile—combining noradrenergic and serotonergic effects with potent antihistamine properties—makes it particularly well-suited for managing the anxiety, insomnia, and mood symptoms that emerged when you stopped Latuda suddenly 4, 5, 6, 8.

The prescription represents sound clinical judgment: addressing immediate withdrawal distress while providing ongoing psychiatric treatment with a medication that has demonstrated safety and efficacy across multiple conditions 10, 9, 13.

References

Guideline

practice parameter on the use of psychotropic medication in children and adolescents.

Journal of the American Academy of Child and Adolescent Psychiatry, 2009

Guideline

clinical guideline for the evaluation and management of chronic insomnia in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

Guideline

palliative care version 1.2016.

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

Research

Mirtazapine: clinical advantages in the treatment of depression.

Journal of clinical psychopharmacology, 1997

Research

Pharmacological update of mirtazapine: a narrative literature review.

Naunyn-Schmiedeberg's archives of pharmacology, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.